ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,499Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 15

$619K Total Retail Price of All Prescriptions

Rank: 2 out of 15

276 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

32% of this provider’s 276 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

37% of this provider’s 276 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 10,088 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $38 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
HYDROCODONE-ACETAMINOPHEN 487 441 S3 1 5
LEVOTHYROXINE SODIUM 447 409 2 3
FUROSEMIDE 411 388 3 4
POTASSIUM CHLORIDE 397 350 4 8
WARFARIN SODIUM 370 359 5 1
OLANZAPINE 320 318 6 39
OMEPRAZOLE 311 285 7 7
CITALOPRAM HBR 302 278 8 10
SERTRALINE HCL 291 277 9 17
TRAZODONE HCL 273 254 10 14
LISINOPRIL 223 194 11 2
POLYETHYLENE GLYCOL 3350 198 150 12 29
FENTANYL 192 176 S2 13 35
CYMBALTA 186 134 14 38
DONEPEZIL HCL 183 183 15 15
AMLODIPINE BESYLATE 182 182 16 9
METFORMIN HCL 174 159 17 16
METOPROLOL TARTRATE 166 130 18 11
GABAPENTIN 156 125 19 12
NAMENDA 153 153 20 19
LANTUS 153 141 20 27
DIVALPROEX SODIUM 134 126 22 44
QUETIAPINE FUMARATE 129 129 23 28
SIMVASTATIN 127 111 24 6
IPRATROPIUM-ALBUTEROL 112 82 25 56
RANITIDINE HCL 109 109 26 22
MIRTAZAPINE 107 107 27 21
METHADONE HCL 103 56 S2 28 75
NOVOLOG 92 83 29 57
METOLAZONE 90 88 30 62
LEVOFLOXACIN 85 65 31 76
PREDNISONE 83 78 32 30
CARBIDOPA-LEVODOPA 81 73 33 32
TAMSULOSIN HCL 80 71 34 26
GLIPIZIDE 77 77 35 45
DIGOXIN 75 75 36 34
ESCITALOPRAM OXALATE 72 55 37 54
AMOXICILLIN 71 68 38 112
CEPHALEXIN 70 65 39 63
MEGESTROL ACETATE 68 65 R 40 117
NYSTOP 65 61 41 93
OLANZAPINE ODT 64 64 42 126
NYSTATIN 61 46 43 132
SPIRONOLACTONE 61 49 43 37
METOPROLOL SUCCINATE 61 61 43 20
TRAMADOL HCL 60 60 46 47
LIDODERM 58 22 47 52
CLOPIDOGREL 57 49 48 50
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 52 49 70
DOXYCYCLINE HYCLATE 54 51 50 139
BACLOFEN 53 12 51 70
ROPINIROLE HCL 53 43 51 87
ABILIFY 53 49 51 78
AZITHROMYCIN 52 46 54 145
CEFTRIAXONE 51 43 55 149
HYDROCHLOROTHIAZIDE 50 38 56 13
ATORVASTATIN CALCIUM 50 39 56 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.